Unilever's health kick is risky prescription – Reuters
Unilever’s health kick is risky prescription – Reuters
Alan Jope can no longer be accused of sitting on his hands. The Unilever (ULVR.L) boss on Monday signalled he would persevere with the attempted acquisition of GlaxoSmithKline’s <a href="h…
